Irisol Pharma Private Limited
About Irisol Pharma Private Limited
Data last updated:
Irisol Pharma Private Limited is a private limited company based in Secunderabad, Telangana, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the support services segment of the services sector. It was incorporated on 29 September 2015.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74120TG2015PTC100963. Its GSTIN is 36AADCI9377E1ZA (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anil Kumar Dodda and Sudheer Amidhepuram.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Flat No. 303 Jyothi Towers Jj Nagar Alwal, Secunderabad, Telangana, India – 500010.
As per the financials filed for FY 2021, the company reported a revenue of ₹41.4 Lakh, a decline of 44% compared to the previous year. For the same year it recorded a net loss of ₹11.91 Lakh (net margin -28.8%) and EBITDA of -₹11.49 Lakh (EBITDA margin -27.7%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 59% over five years.
Company details
Contact details
Irisol Pharma Private Limited's registered office is in Secunderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Social Media
- Registered AddressFlat No. 303 Jyothi Towers Jj Nagar Alwal, Secunderabad, Telangana, India – 500010
- IndustryService, Other Support Services
To see the full contact details of Irisol Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Irisol Pharma is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Irisol Pharma Private Limited, buy the company report.
Financials of Irisol Pharma Private Limited
FY 2023 filings availableIrisol Pharma Private Limited reported revenue of ₹41.4 Lakh (down 44% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue fell 44% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 59%. EBITDA fell 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹11.49 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹11.91 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -27.7% | ||||
| Net Profit Margin | -28.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Irisol Pharma Private Limited, buy the company report.
Board of directors of Irisol Pharma Private Limited
Irisol Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Dodda Also directs: Shanvr Life Sciences Private Limited | Director | 29 Sep 2015 | 11 Years 1 Months | Current |
| Sudheer Amidhepuram Also directs: QMX Pharma LLP, Svaram Pharma Private Limited | Director | 29 Sep 2015 | 11 Years 1 Months | Current |
Peer comparison
Irisol Pharma Private Limited is compared with the 7 companies closest to it by revenue in the same principal business activity (other professional, scientific and technical activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avighna Infratech Private Limited | ₹41.43 Lakh (FY 2017) | 1.0% | Delhi, India | |||
| Shringar Vanijya Private Limited | ₹41.42 Lakh (FY 2024) | 54.0% | Mumbai, Maharashtra, India | |||
| Alma Gyan General Consultancy Private Limited | ₹41.42 Lakh (FY 2023) | 5.0% | Ernakulam, Kerala, India | |||
| Aladinn Technology Private Limited | ₹41.41 Lakh (FY 2018) | 39.0% | Jaipur, Rajasthan, India | |||
| Irisol Pharma Private Limitedthis company | ₹41.4 Lakh (FY 2021) | -₹11.91 Lakh | -28.8% | -44.0% | Secunderabad, Telangana, India | |
| Indexes & IT India Private Limited | ₹41.39 Lakh (FY 2024) | -56.0% | Mumbai, Maharashtra, India | |||
| Lemon Ideas Innovations Private Limited | ₹41.39 Lakh (FY 2025) | 193.0% | Nagpur, Maharashtra, India | |||
| Criblife Lifestyle Management Private Limited | ₹41.38 Lakh (FY 2024) | -46.0% | New Delhi, Delhi, India |
To see the full peer comparison of Irisol Pharma Private Limited, buy the company report.
Auditor
Irisol Pharma Private Limited is audited by A PRASANTH KUMAR for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A PRASANTH KUMAR | FY 2017 | 239148 |
Shareholding
The shareholding of Irisol Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Irisol Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Irisol Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Irisol Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Irisol Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCI9377E1ZA | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Irisol Pharma Private Limited, buy the company report.
Recent activity
Irisol Pharma Private Limited has 3 board changes on record since 2015: 3 appointments. The latest: Anil Kumar Dodda was appointed as Director on 29 Sep 2015.
Frequently asked questions
Irisol Pharma is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.
Irisol Pharma is a company pending strike off, currently registered as a private limited company based in Secunderabad, Telangana, India. The company works in other support services, within the service industry. It was incorporated on 29 September 2015 and is registered under CIN U74120TG2015PTC100963. The company may be struck off soon - caution is advised.
The compliance status of Irisol Pharma is compliant as of 27 July 2026.
Irisol Pharma has 2 current directors:
- Anil Kumar Dodda - Director
- Sudheer Amidhepuram - Director
The CIN (Corporate Identification Number) of Irisol Pharma is U74120TG2015PTC100963. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Irisol Pharma was incorporated on 29 September 2015. It is registered with the Registrar of Companies, Hyderabad.
The registered office of Irisol Pharma is at Flat No. 303 Jyothi Towers Jj Nagar Alwal, Secunderabad, Telangana, India – 500010.
The latest financial statements of Irisol Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Irisol Pharma is 36AADCI9377E1ZA, registered in Telangana.
Irisol Pharma operates in the service industry, in the other support services segment.
The peers of Irisol Pharma by revenue are Avighna Infratech Private Limited, Shringar Vanijya Private Limited, Alma Gyan General Consultancy Private Limited, Aladinn Technology Private Limited, Indexes & IT India Private Limited and 2 more, all in the same principal business activity (other professional, scientific and technical activities).